VaxArray® for Coronavirus
Measure Antigen or Antibody With One Platform
VaxArray reagent kits for spike protein quantification and multiplexed serological assay
Accelerate coronavirus vaccine characterization using the VaxArray Coronavirus Spike Protein Assay kit to rapidly quantify functional spike protein in protein-based vaccines or as a functional potency test for nucleic acid vaccines. The Coronavirus SeroAssay can be used to efficiently quantify the humoral immune response to coronavirus vaccines, with immunogenicity against all human-relevant coronaviruses available from a single test.
Kits Available
Coronavirus SeroAssay
Benefits
- Fast and easy with <30 minutes hands on time and less than 1 hour to result
- Multiplexed analysis of current and past endemic strains
- 100% Clinical Specificity and and 98.5% Clinical Sensitivity
- Compatible with recombinant, peptide, VLP and other advanced vaccine technologies
Applications
- Evaluate serological samples from preclinical and clinical studies
- Screen immunological profile of study participants against all human coronaviruses
- Quantify vaccine immunogenicity
- Confirm cross protection against 7 different coronaviruses
- Research population level seroprevalence
Coronavirus Spike Protein Assay
Benefits
- ~ 1 hour from samples to result. 30 minutes hands on time
-
Analysis of vaccine binding to ACE2 protein
- Lower limit of detection is <15 ng/mL
-
Compatible with recombinant, subunit, VLP, and other advanced vaccine technologies
Applications
- Quantify antigen directly
- Optimize manufacturing process steps
- Control vaccine quality in release testing
- Evaluate stability and ACE2 binding of vaccine
- Characterize vaccine samples
- Monitor vaccine shelf life
Relevant Resources
Other Services
Coronavirus Testing Services
Prefer InDevR to run your samples? Inquire about our standard testing services using this kit.
InDevR can develop a custom kit that improves your vaccine development or serological testing needs.